1. Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy
    Thomas Fröhlich et al, 2016, Sci Rep CrossRef
  2. Molekulare Pathogenese der Fibrose bei Muskeldystrophie vom Typ Duchenne
    K. Ohlendieck et al, 2017, Pathologe CrossRef
  3. Label-free mass spectrometric analysis of themdx-4cvdiaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis
    Ashling Holland et al, 2015, Proteomics CrossRef
  4. The Involvement of Collagen Triple Helix Repeat Containing 1 in Muscular Dystrophies
    Itai Spector et al, 2013, The American Journal of Pathology CrossRef
  5. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy
    STEVEN CARBERRY et al, 2013 CrossRef
  6. Spatial and age-related changes in the microstructure of dystrophic and healthy diaphragms
    Catherine C. Henry et al, 2017, PLoS ONE CrossRef
  7. null
    Rustam R. Mundegar et al, 2018 CrossRef
  8. Application of Fluorescence Two-Dimensional Difference In-Gel Electrophoresis as a Proteomic Biomarker Discovery Tool in Muscular Dystrophy Research
    Steven Carberry et al, 2013, Biology CrossRef
  9. Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers
    Ashling Holland et al, 2015, Molecules CrossRef
  10. Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy
    Sandra Murphy et al, 2015, Biology CrossRef
  11. Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles
    Sandra Murphy et al, 2015, Proteomes CrossRef
  12. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle
    Sandra Murphy et al, 2018, Journal of Proteomics CrossRef
  13. null
    Yichi Zhang et al, 2018 CrossRef
  14. Proteomic profiling of liver tissue from the mdx-4cv mouse model of Duchenne muscular dystrophy
    Sandra Murphy et al, 2018, Clin Proteom CrossRef
  15. Molecular mechanisms of myoprotective action of chondroitin sulfate and glucosamine sulfate in sarcopenia
    O. A. Gromova et al, 2019, Nevrologiâ, nejropsihiatriâ, psihosomatika CrossRef
  16. Proteomic profiling of the mouse diaphragm and refined mass spectrometric analysis of the dystrophic phenotype
    Sandra Murphy et al, 2019, J Muscle Res Cell Motil CrossRef
  17. Elastase levels and activity are increased in dystrophic muscle and impair myoblast cell survival, proliferation and differentiation
    N. Arecco et al, 2016, Sci Rep CrossRef
  18. null
    Steven Carberry et al, 2013 CrossRef
  19. Profiling of Age-Related Changes in theTibialis AnteriorMuscle Proteome of the mdx Mouse Model of Dystrophinopathy
    Steven Carberry et al, 2012, Journal of Biomedicine and Biotechnology CrossRef
  20. Identification of Disease Specific Pathways Usingin VivoSILAC Proteomics in Dystrophin DeficientmdxMouse
    Sree Rayavarapu et al, 2013, Mol Cell Proteomics CrossRef
  21. Proteomic identification of biomarkers of skeletal muscle disorders
    Kay Ohlendieck, 2013, Biomarkers Med. CrossRef
  22. Proteomic profiling of cardiomyopathic tissue from the agedmdxmodel of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin
    Ashling Holland et al, 2013, Proteomics CrossRef
  23. Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy
    Cintia Yuri Matsumura et al, 2013, PLoS ONE CrossRef
  24. Proteomic profiling of the contractile apparatus from skeletal muscle
    Ashling Holland et al, 2013, Expert Review of Proteomics CrossRef
  25. Comparative proteomic analysis of the contractile-protein-depleted fraction from normal versus dystrophic skeletal muscle
    Steven Carberry et al, 2014, Analytical Biochemistry CrossRef
  26. Emerging proteomic biomarkers of X-linked muscular dystrophy
    Paul Dowling et al, 2019, Expert Review of Molecular Diagnostics CrossRef
  27. Affinity proteomics within rare diseases: a BIO ‐ NMD study for blood biomarkers of muscular dystrophies
    Burcu Ayoglu et al, 2014, EMBO Mol Med CrossRef
  28. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse
    Sara Gibertini et al, 2014, Cell Tissue Res CrossRef
  29. Chaperoning heat shock proteins: Proteomic analysis and relevance for normal and dystrophin-deficient muscle
    Heinrich Brinkmeier et al, 2014, Prot. Clin. Appl. CrossRef
  30. Quantitative Proteomic Analysis Reveals Metabolic Alterations, Calcium Dysregulation, and Increased Expression of Extracellular Matrix Proteins in Laminin α2 Chain–deficient Muscle
    Bruno Menezes de Oliveira et al, 2014, Mol Cell Proteomics CrossRef
  31. Circulating Biomarkers for Duchenne Muscular Dystrophy
    Annemieke Aartsma-Rus et al, 2015, JND CrossRef
  32. Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis
    Ashling Holland et al, 2016, Proteomics CrossRef
  33. Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation
    Heidi R. Fuller et al, 2016, Expert Review of Proteomics CrossRef
  34. Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy
    Kristin Strandberg et al, 2020, JND CrossRef
  35. Impact of estrogen deficiency on diaphragm and leg muscle contractile function in female mdx mice
    Pangdra Vang et al, 2021, PLoS ONE CrossRef
  36. Extracellular matrix: an important regulator of cell functions and skeletal muscle development
    Weiya Zhang et al, 2021, Cell Biosci CrossRef
  37. Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy
    Kay Ohlendieck et al, 2021, Pflugers Arch - Eur J Physiol CrossRef
  38. Tyrosine-sulfated dermatopontin shares multiple binding sites and recognition determinants on triple-helical collagens with proteins implicated in cell adhesion and collagen folding, fibrillogenesis, cross-linking, and degradation
    Morten M. Jensen et al, 2022, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef
  39. Proteomic Identification of Markers of Membrane Repair, Regeneration and Fibrosis in the Aged and Dystrophic Diaphragm
    Stephen Gargan et al, 2022, Life CrossRef
  40. Growth-Promoting Effects of Zhenqi Granules on Finishing Pigs
    Wentao Luo et al, 2022, Animals CrossRef
  41. Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways
    Jackie L. McCourt et al, 2023, Skeletal Muscle CrossRef
  42. Myoscaffolds reveal laminin scarring is detrimental for stem cell function while sarcospan induces compensatory fibrosis
    Kristen M. Stearns-Reider et al, 2023, npj Regen Med CrossRef
  43. Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy
    Paul Dowling et al, 2023, Biomolecules CrossRef
  44. Extracellular matrix contribution to disease progression and dysfunction in myopathy
    Ashlee M. Long et al, 2023, American Journal of Physiology-Cell Physiology CrossRef
  45. Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing and pharmacological treatment
    Kalina Andrysiak et al, 2023 CrossRef
  46. How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?
    Paul Dowling et al, 2024, Proteomes CrossRef
  47. null
    Daniel Helzer et al, 2024 CrossRef